NCT06036381 Spatial and Temporal Characterization of Gliomas Using Radiomic Analysis
| NCT ID | NCT06036381 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tata Memorial Centre |
| Condition | Glioma |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-02-15 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2024-02-15 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Glioma are type of primary brain tumors arising within the substance of brain. Different type of gliomas are seen which are classified depending upon pathological examination and advanced molecular techniques, which help to determine the aggressiveness of the tumor and outcomes. Artificial intelligence uses advanced analytical process aided by computer which can be undertaken on the medical images. We plan to use artificial intelligence techniques to identify the abnormal areas within the brain representing tumor from the radiological images. Also, similar approach will be undertaken to classify gliomas with good or bad prognosis, to differentiate glioma from other type of brain tumors, and to detect response after treatment.
Eligibility Criteria
Inclusion Criteria: * Patients with glioma or glioma-mimicking pathology with imaging available in TMC between January 2010 and December 2022. Exclusion Criteria: * Imaging done outside TMC. * Motion artifacts or other artifacts causing image degradation. * Size of tumor or region of interest \< 1 cm in the largest dimension
Contact & Investigator
Dr. ARCHYA DASGUPTA, MD
PRINCIPAL INVESTIGATOR
Tata Memorial Hospital
Frequently Asked Questions
Who can join the NCT06036381 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, studying Glioma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06036381 currently recruiting?
Yes, NCT06036381 is actively recruiting participants. Contact the research team at archya1010@gmail.com for enrollment information.
Where is the NCT06036381 trial being conducted?
This trial is being conducted at Mumbai, India.
Who is sponsoring the NCT06036381 clinical trial?
NCT06036381 is sponsored by Tata Memorial Centre. The principal investigator is Dr. ARCHYA DASGUPTA, MD at Tata Memorial Hospital. The trial plans to enroll 1,000 participants.